TP53 gene polymorphisms and breast cancer in Croatian women: A pilot study

European Journal of Gynaecological Oncology

Volumn 31, Issue 5, 2010, Pages 539-544

  Bisof V ^a   Pericic Salihovic M ^b   Smolej Narancic N ^b   Skaric Juric T ^b   Jakic Razumovic J ^a   Janicijevic B ^b   Turek, S ^b   Rudan, P ^b  

^a KBC Zagreb   (Croatia)

^b INSTITUTE FOR ANTHROPOLOGICAL RESEARCH   (Croatia)

Author keywords

Breast cancer; Polymorphisms; TP53 gene

Indexed keywords

ARGININE; PROLINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; CROATIA; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PILOT STUDY; POLYMERASE CHAIN REACTION;

ADULT; AGED; BREAST NEOPLASMS; CROATIA; FEMALE; GENES, P53; HAPLOTYPES; HUMANS; MIDDLE AGED; ODDS RATIO; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 78549291388     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Pecorino L.: "Molecular biology of cancer". New York, Oxford University Press Inc., 2005, 21.
2. Costa S., Pinto D., Pereira D., Rodrigues H., Cameselle-Teijeiro J., Medeiros R. et al.: "Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms in prediction of susceptibility on breast cancer". BMC Cancer, 2008, 29, 32.
3. Damin A.P.S., Frazzon A.P.G., Damin D.C., Rodrigues H., Cameselle-Teijeiro J., Medeiros R. et al.: "Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk". Cancer Detect. Prev., 2006, 30, 523.
4. Hamroun D., Kato S., Ishioka C., Claustres M., Béroud C., Soussi T.: "The UMD TP53 database and website: update and revisions". Hum. Mutat., 2006, 27, 14.
5. Collins A., Lonjou C., Morton N.E.: "Genetic epidemiology of single-nucleotide polymorphisms". PNAS, 1999, 96, 15173.
6. http://www-p53.iarc.fr
7. Buyru N., Tigli H., Dalay N.: "P53 codon 72 polymorphism in breast cancer". Oncol. Rep., 2003, 10, 711.
8. Mabrouk I., Baccouche S., El-Abed R., Mokdad-Gargouri R., Mosbah A., Said S. et al.: "No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients". Ann. N Y Acad. Sci., 2003, 1010, 764.
9. Papadakis E.N., Dokianakis D.N., Spandidos D.A.: "P53 codon 72 polymorphism as a risk factor in the development of breast cancer". Mol. Cell. Biology Res. Comm., 2000, 3, 389.
10. Buyru N., Altinisk J., Demokan S., Dalay N.: "P53 genotypes and haplotypes associated with risk of breast cancer". Cancer Detect. Prev., 2007, 31, 207.
11. Wang-Gohrke S., Becher H., Kreienberg R., Runnebaum I.B., Chang-Claude J.: "Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years". Pharmacogenetics, 2002, 12, 269.
12. The International HapMap Consortium: "The International HapMap Project". Nature, 2003, 426, 789.
13. Sobin L.H., Wittekind Ch., (eds.). International Union Against Cancer, TNM classification of malignant tumours. New York, Wiley-Liss, 1997, 131.
14. Turek S., Rudan I., Smolej Narančić N., Szirovicza L., Cubrilo-Turek M., Zerjavic-Hrabak V. et al.: "A large cross-sectional study of health attitudes, knowledge, behaviour and risks in the post-war Croatian population". Coll. Antropol., 2001, 25, 77.
15. Poncz M., Solowiejcyk D., Harvel B., Mory Y., Schwartz E., Surrey S.: "Construction of human gene libraries from small amounts of peripheral blood: Analysis of β-like globin genes". Hemoglobin, 1982, 6, 27.
16. Schneider S., Roessli D., Excoffier L.: "Arlequin ver. 2000: A software for population genetic data analysis". Genetics and Biometry Laboratory, University of Geneva, Switzerland, 2000.
17. Lewontin R.C.: "The interaction of selection and linkage, I. General considerations; heterotic models". Genetics, 1964, 49, 49.
18. Noma C., Miyoshi Y., Taguchi T., Tamaki Y., Noguchi S.: "Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women". Cancer Lett., 2004, 210, 197.
19. Själander A., Birgander R., Hallmans G., Cajander S., Lenner P., Athlin L. et al.: "P53 polymorphisms and haplotypes in breast cancer". Carcinogenesis, 1996, 17, 1313.
20. Vieira J.O., da Silva I.D., Higo P.E., Nogueira-de-Souza N.C., Gebrim L.H.: "Study of p53 codon 72 polymorphism in patients with breast cancer". Eur. J. Gynaecol. Oncol., 2008, 29, 364.
21. Bonafé M., Ceccarelli C, Farabegoli F., Santini D., Taffurelli M., Barbi C. et al.: "Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients". Clin. Cancer Res., 2003, 9, 4860.
22. Han W., Kang D., Park I.A., Kim S.W., Bae J.Y., Chung K.W. et al.: "Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features". Clin. Cancer Res., 2004, 10, 124.
23. Powell B.L., van Staveren I.L., Roosken P., Grieu P., Berns E.M.J.J. et al.: "Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer". Carcinogenesis, 2002, 23, 311.
24. Singh V., Rastogi N., Mathur N., Singh K., Singh M.P.: "Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women". Ann. Epidemiol., 2008, 18, 48.
25. Franekova M., Zubor P., Stanclova A., Dussan C., Bohusova T., Galo S. et al.: "Association of p53 polymorphism with breast cancer: a case-control study in Slovak population". Neoplasma, 2007, 54, 155.
26. Ma H., Hu Z., Zhai X., Wang S., Wang X., Qin J. et al.: "Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population". Carcinogenesis, 2006, 27, 766.
27. Kalemi T.G., Lambropoulos A.F., Gueorguiev M., Chrisafi S., Papazisis K.T., Kotsis A.: "The association of p53 mutations and p53 codon 72, HER 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece". Cancer Lett., 2005, 222, 57.
28. Suspitsin E.N., Buslov K.G., Grigorjev M.Y., Ishutkina J.G., Ulbina J.M., Gorodinskaya V.M. et al.: "Evidence against involvement of P53 polymorphism in breast cancer predisposition". Int. J. Cancer, 2003, 103, 431.
29. Mahasneh A.A., Abdel-Hafiz S.S.: "Polymorphism of p53 gene in Jordanian population and possible associations with breast cancer and lung adenocarcinoma". Saudi Med. J., 2004, 25, 568.
30. Breast Cancer Association Consortium: "Commonly studied single-nucleotide polymorphisms and breast cancer: results from the breast cancer association consortium". J. Nat. Cancer Inst., 2006, 98, 1382.
31. Khadang B., Fattahi M.J., Talei A., Dehaghani A.S., Ghaderi A.: "Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women". Cancer Genet. Cytogen., 2007, 173, 38.
32. Wei Z., Ming-Juan J., Kun C., Yong-Jing Z., Shuang-Shuang Z., Xin-Yuan M. et al.: "Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer". Zhejiang Da Xue Xue Bao Yi Xue Ban, 2007, 36, 561.
33. Excoffier L., Slatkin M.: "Incorporating genotypes of relatives into a test of linkage disequilibrium". Am. J. Hum. Genet., 1998, 62, 171.
34. Weston A., Pan C.F., Ksieski H.B., Wallenstein S., Berkowitz G.S., Tartter P.I. et al.: "P53 haplotype determination in breast cancer". Cancer Epidemiol. Biomarkers Prev., 1997, 6, 105.
35. Khaliq S., Hameed A., Khaliq T., Ayub Q., Qamar R., Mohyuddin A. et al.: "P53 mutations, polymorphisms and haplotypes in Pakistani ethnic groups and breast cancer patients". Genet. Testing, 2000, 4, 23.
36. Pietsch E.C., Humbey O., Murphy M.E.: "Polymorphisms in the p53 pathway". Oncogene, 2006, 25, 1602.
37. Soussi T.: "Analysis of P53 gene alterations in cancer: a critical view". In: Wiamn K., Hainaout P. (eds.) 25 years of p53 research. The Netherlands, Springer, 2005, 225.
38. Petitjean A., Achatz M.I.W., Børresen-Dale A.L., Hainaut P., Olivier M.: "TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes". Oncogene, 2007, 26, 2157.
39. Wu X., Zhao H., Amos C.I., Shete S., Makan N., Hong W.K. et al.: "P53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity". J. Nat. Cancer Instit., 2002, 94, 681.
40. Gemiganani F., Moreno V., Landi S., Moullan N., Chabrier A., Gutiérrez-Enriquez S. et al.: "A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA". Oncogene, 2004, 23, 1954.